Provided by Tiger Fintech (Singapore) Pte. Ltd.

MannKind

4.99
+0.01000.20%
Post-market: 4.96-0.0300-0.60%19:51 EDT
Volume:2.82M
Turnover:13.88M
Market Cap:1.51B
PE:49.90
High:5.04
Open:4.91
Low:4.77
Close:4.98
Loading ...

MannKind reports six-month results from Phase 3 INHALE-1 trial

TIPRANKS
·
16 Dec 2024

MannKind Announces Six-Month Results From Phase 3 Inhale-1 Pediatric Diabetes Trial Utilizing Inhaled Insulin (Afrezza®)

THOMSON REUTERS
·
16 Dec 2024

MannKind Corp - Plans to Meet With FDA for Snda Submission in 1H 2025

THOMSON REUTERS
·
16 Dec 2024

MannKind Corp: Primary Endpoint Was Non-Inferior Change in Hba1c Levels After 26 Weeks

THOMSON REUTERS
·
16 Dec 2024

MannKind's (NASDAQ:MNKD) investors will be pleased with their incredible 393% return over the last five years

Simply Wall St.
·
12 Dec 2024

BUZZ-MannKind rises after India approves insulin inhalation powder

Reuters
·
11 Dec 2024

MannKind, Cipla Say Afrezza Inhalation Powder Approved for Diabetes in India

MT Newswires Live
·
11 Dec 2024

MannKind Corp: Expects to Ship Product for Cipla Ltd. by End of 2025

THOMSON REUTERS
·
11 Dec 2024

MannKind Corp: Central Drugs Standard Control Organisation (Cdsco) in India Has Approved Afrezza Inhalation Powder in Adults

THOMSON REUTERS
·
11 Dec 2024

Optimistic Buy Rating for MannKind’s MNKD-201 Program Bolstered by Inhaled Drug Development Success

TIPRANKS
·
25 Nov 2024

Tudor Pickering Holt Downgrades MannKind to Hold From Buy, Adjusts Price Target to $5.50 From $7

MT Newswires Live
·
15 Nov 2024

MannKind’s Growth Momentum and Increased Confidence in Pipeline Elevate Buy Rating

TIPRANKS
·
11 Nov 2024

MannKind Third Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag

Simply Wall St.
·
09 Nov 2024

MannKind price target raised to $7 from $5 at RBC Capital

TIPRANKS
·
09 Nov 2024

RBC Capital Adjusts Price Target on MannKind to $7 From $5, Maintains Sector Perform Rating

MT Newswires Live
·
08 Nov 2024

Stock Track | MannKind Shares Plunge Despite Q3 Beat as Afrezza Concerns Linger

Stock Track
·
08 Nov 2024